Pathogenesis of sarcopenia in chronic obstructive pulmonary disease
Authors:
Open Access
- 19 July 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 13, 850964
Abstract
Chronic obstructive pulmonary disease (COPD) is a common pulmonary disease characterized by persistent respiratory symptoms and airflow obstruction. In addition to lung diseases, chronic obstructive pulmonary disease (COPD) is often associated with other organ diseases, and sarcopenia is one of the common diseases. In recent years, multiple factors have been proposed to influence muscle dysfunction in COPD patients, including systemic and local inflammation, oxidative stress, hypoxia, hypercapnia, protein synthesis, catabolic imbalance, nutritional changes, disuse, ageing, and the use of medications such as steroids. These factors alone or in combination can lead to a reduction in muscle mass and cross-sectional area, deterioration of muscle bioenergy metabolism, defects in muscle repair and regeneration mechanisms, apoptosis and other anatomical and/or functional pathological changes, resulting in a decrease in the muscle’s ability to work. This article reviews the research progress of possible pathogenesis of sarcopenia in COPD.Keywords
Funding Information
- Key Scientific Research Project of Colleges and Universities in Henan Province
This publication has 78 references indexed in Scilit:
- Ghrelin Treatment of Cachectic Patients with Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialPLOS ONE, 2012
- Cigarette smoke‐induced skeletal muscle atrophy is associated with up‐regulation of USP‐19 via p38 and ERK MAPKsJournal of Cellular Biochemistry, 2011
- Identification of Genes that Elicit Disuse Muscle Atrophy via the Transcription Factors p50 and Bcl-3PLOS ONE, 2011
- FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin‐1/MAFbx expression during glucocorticoid‐induced skeletal muscle atrophyThe FASEB Journal, 2010
- Reactive oxygen species are signalling molecules for skeletal muscle adaptationExperimental Physiology, 2009
- Nuclear factor-kappa B signaling in skeletal muscle atrophyJournal of Molecular Medicine, 2008
- Lipofuscin accumulation in the vastus lateralis muscle in patients with chronic obstructive pulmonary diseaseMuscle & Nerve, 2002
- Among translational effectors, p70S6k is uniquely sensitive to inhibition by glucocorticoidsBiochemical Journal, 2000
- Inhibition of -ATPase by phenoxyl radicals of etoposide (VP-16): role of sulfhydryls oxidationBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1995
- Effect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue.Thorax, 1994